This observational study aims to better understand functional mitral regurgitation (FMR), a common heart condition, using a special type of heart scan called Cardiac Magnetic Resonance (CMR). Researchers want to create a more personalized way to predict risks for FMR patients and see how CMR can help identify patients who might benefit most from current treatments. You might be able to join if you are an adult (18 or older) with a specific heart pumping ability (LVEF <55%) and at least moderate FMR, as well as certain kidney function (eGFR >15). The study will use CMR scans to learn more about your heart. The main goal is to track outcomes like heart-related death, heart transplant, or LVAD implantation for up to 36 months. The study is currently recruiting 360 participants.

Study design

This is an observational study, meaning researchers will gather information without assigning specific treatments. It aims to enroll 360 adult participants.

What's involved

You will undergo a Cardiac Magnetic Resonance (CMR) scan at the start and again at 6 months. If you are referred for MitraClip, a CMR will be performed 6 months after that procedure.

Compensation

Not stated in the trial record.

Follow-up

The study will track outcomes like cardiac mortality, heart transplant, or LVAD implantation for up to 36 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.